// PERSON
Anna Kazatskaya
ROLE CO-FOUNDER & CEOMENTIONS 1LAST SEEN AUGUST 2, 2026
// BIO
Anna Kazatskaya is a molecular biology PhD and biotech founder based in the Greater Boston area. She is the CEO of Fervid Therapeutics (previously operating under the name AntoZero), a company developing a novel anti-seizure therapy for rare pediatric developmental and epileptic encephalopathies by promoting the formation of new inhibitory synapses. She holds a Ph.D. in Molecular and Cellular Biology from Brandeis University and has prior industry experience at Stoke Therapeutics and Vertex Pharmaceuticals.
Discussed in
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
mention·Data Driven VC·AUGUST 2, 2026
“Co-founder & CEO of stealth drug discovery startup (miniature human neural networks for neurodegeneration & brain aging).”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.